Black Rock Inc. Ptc Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,565,086 shares of PTCT stock, worth $231 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,565,086
Previous 7,634,122
0.9%
Holding current value
$231 Million
Previous $210 Million
4.6%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding PTCT
# of Institutions
198Shares Held
83.7MCall Options Held
192KPut Options Held
129K-
Vanguard Group Inc Valley Forge, PA9.37MShares$287 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.9MShares$272 Million0.05% of portfolio
-
Rtw Investments, LP New York, NY7.42MShares$227 Million3.47% of portfolio
-
Armistice Capital, LLC New York, NY6.76MShares$207 Million2.68% of portfolio
-
State Street Corp Boston, MA4.11MShares$126 Million0.01% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.19B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...